Alkermes   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Waltham MA United States (1987)

Organization Overview

First Clinical Trial
1999
NCT00002316
First Marketed Drug
1997
ketoprofen (orudis)
First NDA Approval
2015
aripiprazole (abilify)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ALKERMES | ALKERMES GAINESVILLE | Alkermes, Inc. | ALKERMES INC | Alkermes Medical Director